These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 5824711)

  • 1. [On the activity of erythromycin: clinical study of 135 cases].
    Casoni I; Malaguti P; Russomanno E
    Minerva Med; 1969 Aug; 60(69):3133-6. PubMed ID: 5824711
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experimentation with an antibiotic: erythromycin stearate].
    Linquette M; Decoulx M
    Lille Med; 1967 May; 12(4):Suppl:524-8. PubMed ID: 5619706
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of sepsis in infants with an association of erythromycin and chloramphenicol].
    Caruso F
    Clin Ter; 1969 Feb; 48(4):341-8. PubMed ID: 5355892
    [No Abstract]   [Full Text] [Related]  

  • 4. [The use of erythromycin in bacterial infections in infants and children].
    Nodari R
    Minerva Pediatr; 1969 Oct; 21(42):1957-60. PubMed ID: 5403320
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythromycin in lower respiratory infections.
    Practitioner; 1970 Feb; 204(220):315-7. PubMed ID: 4906769
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tolerance and efficiency of erythromycin suppositories used in respiratory infections in ambulatory pediatric practice].
    Rodovalho SF
    Hospital (Rio J); 1968 Jun; 73(6):1947-52. PubMed ID: 5306207
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ethyl succinate erythromycin and trisulphapyridine combination in the treatment of respiratory infections in pediatric outpatients].
    de Santana AF
    Hospital (Rio J); 1969 Apr; 75(4):1429-38. PubMed ID: 5306432
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study "in vitro" and "in vivo" using erythromycin stearate in the therapy of respiratory and cutaneous infections].
    Levy A; Martinez AA; de Castro ML
    Rev Bras Med; 1968 Dec; 25(12):836-40. PubMed ID: 5717048
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mycoplasmic pneumonia and respiratory tract inflammation].
    Kitamoto O
    Naika; 1971 Jun; 27(6):1225-7. PubMed ID: 5092035
    [No Abstract]   [Full Text] [Related]  

  • 10. [Erythromycin and josamycin in respiratory tract infections in children. Comparative therapeutic results].
    Behre U; Wolters K; Daschner FD
    MMW Munch Med Wochenschr; 1980 Jun; 122(25):941-2. PubMed ID: 6772944
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use in pediatrics of a new form of erythromycin: erythromycin ethyl succinate].
    Raveau MJ
    J Med Lyon; 1969 Mar; 50(160):403-9. PubMed ID: 5784250
    [No Abstract]   [Full Text] [Related]  

  • 12. Clarithromyocin new approaches to the treatment of respiratory tract infection. Seventh Mediterranean Congress of Chemotherapy. Barcelona, Spain, May 1990.
    J Antimicrob Chemother; 1991 Feb; 27 Suppl A():1-124. PubMed ID: 1827093
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of a secretolytic agent (bromhexine) on the penetration of erythromycin into bronchial secretions].
    Bergogne-Berezin E; Pierre J; Dournovo P
    Fortschr Med; 1982 Jun; 100(24):1169-71. PubMed ID: 7049878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antimicrobial therapy in ro cases of obstructive chronic bronchopneumopathy].
    Noya M; Del Río A
    Rev Clin Esp; 1971 Apr; 121(1):47-50. PubMed ID: 5563102
    [No Abstract]   [Full Text] [Related]  

  • 15. [Contribution to the study of erythromycin combined with betaine, in controlling the most common toxi-infectious states in medical practice].
    Ogawa P
    Rev Bras Med; 1971 Mar; 28(3):132-4. PubMed ID: 5556805
    [No Abstract]   [Full Text] [Related]  

  • 16. Twice daily dosing of erythromycin acistrate in the treatment of acute bronchitis and pneumonia.
    Wiesner B; Wilen-Rosenqvist G; Lehtonen L
    Arzneimittelforschung; 1993 Sep; 43(9):1014-7. PubMed ID: 8240450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased erythromycin use after antimicrobial reimbursement restriction for undocumented bacterial upper respiratory tract infections significantly reduced erythromycin resistance in Streptococcus pyogenes in Taiwan.
    Hsueh PR; Shyr JM; Wu JJ
    Clin Infect Dis; 2005 Mar; 40(6):903-5. PubMed ID: 15736030
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
    Amsden GW
    J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythromycin-sulfas in pediatric practice: efficacy and patient acceptance.
    Chisholm WS
    Ariz Med; 1968 Aug; 25(8):707-9. PubMed ID: 5674274
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical trial of erythromycin stearate in surgery (44 cases)].
    Lagache G; Proye C
    Lille Med; 1969 Feb; 14(2):98-102. PubMed ID: 5384131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.